Pancreatic Cancer Action Network
Tracked across 2 events · 98 articles · First seen Jul 20, 2026 · Last active Aug 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: PanCAN confirmed the approval and expressed concern about patient out-of-pocket costs, advocating for affordable access to the new therapy. The organization supports research into KRAS-targeting drugs.
Aug 26, 2026 · 92 articles
Tech
Impact: Provided funding; advances its advocacy goals.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Pancreatic Cancer Action Network live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard